
Trillium Therapeutics (TRIL)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Trillium Therapeutics (TRIL) Stock
Start investing in Trillium Therapeutics (TRIL)
About Trillium Therapeutics (TRIL)
Market cap | $1.64B |
Today's volume | — |
Revenue (TTM) | — |
Avg. daily volume | 3.25M |
EBITDA (TTM) | — |
Open | — |
Price / earnings ratio | 74.87x |
Today's range | — |
Debt / equity | — |
52 week range | $5.8 - $20.96 |
5 year debt / equity | -12.28x |
Beta (LTM) | 1.16x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | — |
Ex-dividend date | — |
Next earnings | Nov 12, 2021 |
Dividend payable date | — |
Trillium Therapeutics Stock News
View all



Frequently Asked Questions (FAQ)
How to buy TRIL stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in TRIL stock
Navigate to the Explore page. Then, type TRIL into the search bar. When you see TRIL stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased TRIL stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Trillium Therapeutics Stock Earnings
The value each TRIL share was expected to gain vs. the value that each TRIL share actually gained.
Trillium Therapeutics (TRIL) reported Q3 2021 earnings per share (EPS) of -$0.18, beating estimates of -$0.20 by 10.00%. In the same quarter last year, Trillium Therapeutics's earnings per share (EPS) was -$0.55. Trillium Therapeutics is expected to release next earnings on 11/12/2021, with an earnings per share (EPS) estimate of $0.